ITRM20000491A0 - Formulazione farmaceutica di propionato di fluticasone. - Google Patents

Formulazione farmaceutica di propionato di fluticasone.

Info

Publication number: ITRM20000491A0
Authority: IT; Italy
Prior art keywords: pharmaceutical formulation; fluticasone propionate; fluticasone; propionate; formulation
Prior art date: 1999-09-11

Application number

IT2000RM000491A

Other languages

English (en)

Inventor

Alan Leslie Cripps

Paul Johnson

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-11

Filing date

2000-09-11

Publication date

2000-09-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITRM20000491(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-09-11 Priority claimed from GBGB9921396.9A external-priority patent/GB9921396D0/en

2000-06-13 Priority claimed from GB0014451A external-priority patent/GB0014451D0/en

2000-07-28 Priority claimed from GB0018654A external-priority patent/GB0018654D0/en

2000-09-11 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2000-09-11 Publication of ITRM20000491A0 publication Critical patent/ITRM20000491A0/it

2002-03-11 Publication of ITRM20000491A1 publication Critical patent/ITRM20000491A1/it

2003-07-15 Application granted granted Critical

2003-07-15 Publication of IT1317904B1 publication Critical patent/IT1317904B1/it

Links

229960000289 fluticasone propionate Drugs 0.000 title 1
WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

IT2000RM000491A 1999-09-11 2000-09-11 Formulazione farmaceutica di propionato di fluticasone. IT1317904B1 (it)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9921396.9A GB9921396D0 (en)	1999-09-11	1999-09-11	Pharmaceutical formulation
GB0014451A GB0014451D0 (en)	2000-06-13	2000-06-13	Pharmaceutical formulation
GB0018654A GB0018654D0 (en)	2000-07-28	2000-07-28	Pharmaceutical formulation

Publications (3)

Publication Number	Publication Date
ITRM20000491A0 true ITRM20000491A0 (it)	2000-09-11
ITRM20000491A1 ITRM20000491A1 (it)	2002-03-11
IT1317904B1 IT1317904B1 (it)	2003-07-15

Family

ID=27255761

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT2000RM000491A IT1317904B1 (it)	1999-09-11	2000-09-11	Formulazione farmaceutica di propionato di fluticasone.

Country Status (12)

Country	Link
US (4)	US6479035B1 (it)
EP (1)	EP1143930B8 (it)
JP (1)	JP2003509359A (it)
AT (1)	ATE343374T1 (it)
AU (1)	AU7026800A (it)
CA (1)	CA2317999C (it)
DE (1)	DE60031504T2 (it)
ES (1)	ES2274803T3 (it)
FR (4)	FR2798290B1 (it)
GB (1)	GB2354007B (it)
IT (1)	IT1317904B1 (it)
WO (1)	WO2001019342A2 (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9814717D0 (en) *	1998-02-23	1998-09-02	Bespak Plc	Improvements in drug delivery devices
AU7026800A (en) *	1999-09-11	2001-04-17	Glaxo Group Limited	Pharmaceutical formulation of fluticasone propionate
ES2238334T3 (es) *	1999-12-24	2005-09-01	Glaxo Group Limited	Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317720B1 (it) *	2000-01-07	2003-07-15	Chiesi Farma Spa	Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
EP1321159A1 (en)	2001-12-21	2003-06-25	CHIESI FARMACEUTICI S.p.A.	Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
US7482366B2 (en)	2001-12-21	2009-01-27	X-Ceptor Therapeutics, Inc.	Modulators of LXR
WO2003059884A1 (en)	2001-12-21	2003-07-24	X-Ceptor Therapeutics, Inc.	Modulators of lxr
EP3384931B1 (en) *	2002-03-01	2019-07-24	Chiesi Farmaceutici S.p.A.	Formoterol superfine formulation
EP1340492A1 (en) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Aerosol formulations for pulmonary administration of medicaments having systemic effects
US20040265238A1 (en) *	2003-06-27	2004-12-30	Imtiaz Chaudry	Inhalable formulations for treating pulmonary hypertension and methods of using same
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US8367734B1 (en)	2005-08-11	2013-02-05	Amphastar Pharmaceuticals Inc.	Stable epinephrine suspension formulation with high inhalation delivery efficiency
ES2432361T3 (es) *	2005-12-02	2013-12-03	Bayer Healthcare, Llc	Derivados de pirrolotriazina útiles para el tratamiento de cáncer por inhibición de cinasa Aurora
GB0712454D0 (en) *	2007-06-27	2007-08-08	Generics Uk Ltd	Pharmaceutical compositions
NZ624922A (en)	2009-10-01	2016-05-27	Adare Pharmaceuticals Inc	Orally administered corticosteroid compositions
TWI399202B (zh)	2011-03-17	2013-06-21	Intech Biopharm Ltd	製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
GB201108039D0 (en) *	2011-05-13	2011-06-29	Mexichem Amanco Holding Sa	Compositions
CN102379846B (zh) *	2011-10-21	2014-07-02	江苏长风药业有限公司	以氢氟烷烃和聚乙二醇为辅料氟替卡松丙酸酯气雾剂制剂
US8765725B2 (en)	2012-05-08	2014-07-01	Aciex Therapeutics, Inc.	Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
AU2013259872B2 (en)	2012-05-08	2018-06-28	Nicox Ophthalmics, Inc.	Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9815865B2 (en)	2013-01-07	2017-11-14	Nicox Ophthalmics, Inc.	Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
WO2015034678A2 (en)	2013-09-06	2015-03-12	Aptalis Pharmatech, Inc.	Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI728172B (zh)	2016-08-18	2021-05-21	美商愛戴爾製藥股份有限公司	治療嗜伊紅性食道炎之方法
EP3797964B1 (en)	2019-09-26	2023-06-07	Presspart Manufacturing S.A.	Injection molding tool for metered dose inhaler
US20230271770A1 (en) *	2020-04-21	2023-08-31	Amphastar Pharmaceuticals, Inc.	Anti-Viral Pharmaceutical Formulations Administered Via Devices for Lung Targeted Delivery
US12514995B2 (en)	2021-02-15	2026-01-06	Glenmark Pharmaceuticals Limited	Metered dose inhalers of fluticasone or an ester thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE629985A (it) *	1962-11-29
CH634480A5 (de) *	1977-11-25	1983-02-15	Schwarzkopf Gmbh Hans	Unter druck stehendes aerosolpraeparat.
DE2949933A1 (de)	1979-12-12	1981-06-19	Wabco Fahrzeugbremsen Gmbh, 3000 Hannover	Vorrichtung zum verhindern von schlingerbewegungen eines anhaengers
GB8828477D0 (en) *	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
IL95590A (en)	1989-09-08	1996-06-18	Glaxo Group Ltd	Medicinal preparations containing Salmetrol and Pluticasone Propionate
GB2235627B (en)	1989-09-08	1993-09-01	Glaxo Group Ltd	Inhalation medicaments for treating respiratory disorders
US5270305A (en) *	1989-09-08	1993-12-14	Glaxo Group Limited	Medicaments
US5919827A (en)	1990-07-11	1999-07-06	Sepracor Inc.	Method for treating asthma using optically pure R(-) salmeterol
JP2769925B2 (ja)	1990-10-18	1998-06-25	ミネソタマイニングアンドマニュファクチャリングカンパニー	ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
MX9203481A (es) *	1990-10-18	1992-07-01	Minnesota Mining & Mfg	Formulaciones.
US5683676A (en)	1991-12-12	1997-11-04	Glaxo Group Limited	Canister containing aerosol formulations containing P134a and particulate medicaments
ES2079210T3 (es)	1991-12-12	1996-01-01	Glaxo Group Ltd	Formulacion farmaceutica de aerosol.
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5736124A (en) *	1991-12-12	1998-04-07	Glaxo Group Limited	Aerosol formulations containing P134a and particulate medicament
US5658549A (en) *	1991-12-12	1997-08-19	Glaxo Group Limited	Aerosol formulations containing propellant 134a and fluticasone propionate
SK280911B6 (sk)	1992-12-09	2000-09-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Farmaceutický prostriedok
GB9313650D0 (en) *	1993-07-01	1993-08-18	Glaxo Group Ltd	Method and apparatus for the formation of particles
DE4446891A1 (de) *	1994-12-27	1996-07-04	Falk Pharma Gmbh	Stabile wäßrige Budesonid-Lösung
MX9707862A (es) *	1995-04-14	1997-11-29	Glaxo Wellcome Inc	Inhalador de dosis medida para el propionato de fluticasona.
NZ336049A (en)	1996-12-04	2000-09-29	Bioglan Ireland R & D Ltd	Aersol device for administering pharmaceutical active agents in a solution of propellant, carrier and valve means for delivering this to the exterior of the container
AU718967B2 (en) *	1997-02-05	2000-05-04	Jagotec Ag	Medical aerosol formulations
GB2326334A (en)	1997-06-13	1998-12-23	Chiesi Farma Spa	Pharmaceutical aerosol compositions
US6309623B1 (en) *	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
GB2332372B (en) *	1997-12-08	2002-08-14	Minnesota Mining & Mfg	Pharmaceutical aerosol compositions
DE69909771T2 (de)	1998-04-30	2004-04-15	3M Innovative Properties Co., Saint Paul	Dosierventil für pharmazeutisches aerosol
CN1161104C (zh)	1998-06-18	2004-08-11	贝林格尔·英格海姆药物公司	有二种或多种活性物质的气溶胶药物制剂
US6241969B1 (en) *	1998-06-26	2001-06-05	Elan Corporation Plc	Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
JP4570251B2 (ja) *	1998-07-24	2010-10-27	ヤゴテックアーゲー	医薬用エーロゾル製剤
IT1303788B1 (it)	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
US6004537A (en)	1998-12-18	1999-12-21	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9903759D0 (en)	1999-02-18	1999-04-14	Novartis Ag	Organic compounds
US6231519B1 (en) *	1999-05-04	2001-05-15	Nokia Corporation	Method and apparatus for providing air quality analysis based on human reactions and clustering methods
US6315985B1 (en) *	1999-06-18	2001-11-13	3M Innovative Properties Company	C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AU7026800A (en) *	1999-09-11	2001-04-17	Glaxo Group Limited	Pharmaceutical formulation of fluticasone propionate
DE60017450T2 (de)	1999-11-23	2006-03-02	Glaxo Group Ltd., Greenford	Pharmazeutische formulierungen enthaltend salmeterol
GB0002798D0 (en)	2000-02-09	2000-03-29	Glaxo Group Ltd	Actuator nozzle for metered dose inhaler

2000
- 2000-09-11 AU AU70268/00A patent/AU7026800A/en not_active Abandoned
- 2000-09-11 EP EP00958854A patent/EP1143930B8/en not_active Revoked
- 2000-09-11 US US09/659,492 patent/US6479035B1/en not_active Expired - Fee Related
- 2000-09-11 CA CA002317999A patent/CA2317999C/en not_active Expired - Fee Related
- 2000-09-11 WO PCT/GB2000/003471 patent/WO2001019342A2/en not_active Ceased
- 2000-09-11 FR FR0011547A patent/FR2798290B1/fr not_active Expired - Fee Related
- 2000-09-11 GB GB0022222A patent/GB2354007B/en not_active Expired - Fee Related
- 2000-09-11 DE DE60031504T patent/DE60031504T2/de not_active Expired - Lifetime
- 2000-09-11 AT AT00958854T patent/ATE343374T1/de not_active IP Right Cessation
- 2000-09-11 ES ES00958854T patent/ES2274803T3/es not_active Expired - Lifetime
- 2000-09-11 JP JP2001522977A patent/JP2003509359A/ja active Pending
- 2000-09-11 IT IT2000RM000491A patent/IT1317904B1/it active
2002
- 2002-03-05 FR FR0202756A patent/FR2820322B1/fr not_active Expired - Fee Related
- 2002-07-19 US US10/198,364 patent/US6630129B2/en not_active Expired - Fee Related
2003
- 2003-07-31 US US10/630,655 patent/US7220403B2/en not_active Expired - Fee Related
- 2003-08-04 FR FR0309598A patent/FR2843882B1/fr not_active Expired - Fee Related
2004
- 2004-01-21 FR FR0400541A patent/FR2848453B1/fr not_active Expired - Fee Related
- 2004-02-10 US US10/774,393 patent/US20040157815A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1143930A3 (en)	2002-09-11
US6630129B2 (en)	2003-10-07
GB0022222D0 (en)	2000-10-25
DE60031504T2 (de)	2007-04-05
ATE343374T1 (de)	2006-11-15
FR2848453B1 (fr)	2010-09-03
EP1143930B8 (en)	2008-03-19
ITRM20000491A1 (it)	2002-03-11
FR2843882B1 (fr)	2011-04-22
IT1317904B1 (it)	2003-07-15
GB2354007A (en)	2001-03-14
FR2820322B1 (fr)	2005-03-11
WO2001019342A2 (en)	2001-03-22
FR2820322A1 (fr)	2002-08-09
FR2798290A1 (fr)	2001-03-16
US20040037783A1 (en)	2004-02-26
AU7026800A (en)	2001-04-17
FR2848453A1 (fr)	2004-06-18
FR2843882A1 (fr)	2004-03-05
GB2354007B (en)	2003-10-22
JP2003509359A (ja)	2003-03-11
US7220403B2 (en)	2007-05-22
ES2274803T3 (es)	2007-06-01
DE60031504D1 (de)	2006-12-07
US20030086876A1 (en)	2003-05-08
EP1143930A2 (en)	2001-10-17
US20040157815A1 (en)	2004-08-12
CA2317999A1 (en)	2001-03-11
CA2317999C (en)	2004-11-09
WO2001019342A3 (en)	2001-08-09
FR2798290B1 (fr)	2003-09-12
EP1143930B1 (en)	2006-10-25
US6479035B1 (en)	2002-11-12

Publication	Publication Date	Title
ITRM20000491A0 (it)	2000-09-11	Formulazione farmaceutica di propionato di fluticasone.
NO20022998L (no)	2002-08-15	Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
PT1221918E (pt)	2005-06-30	Administracao de drogas sub-tenon
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
FIU20000164U0 (fi)	2000-04-11	Uusi farmaseuttinen formulaatio
NO20033384D0 (no)	2003-07-29	Farmasöytisk formulering
DK1073417T3 (da)	2003-03-24	Farmaceutisk aerosolformulering
NO20033556D0 (no)	2003-08-11	Farmasöytiske preparater
IS5953A (is)	2001-05-25	Lyfjablöndur úr örgerðum eplerenonum
NO20071303L (no)	2001-07-27	Farmasoytiske preparater
NO20033785D0 (no)	2003-08-26	Farmasöytisk formulering
NO20020086L (no)	2002-03-05	Smaksmaskerte farmasöytiske flytende formuleringer
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
NO20015670L (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
NO20040047L (no)	2004-02-23	Farmasoytisk formulering for intramuskulaer administrering av fulvestrant
NO20014926L (no)	2001-12-13	Farmasöytiske forbindelser
FR2802423B1 (fr)	2005-03-25	Compositions pharmaceutiques
ID30032A (id)	2001-11-01	Formulasi farmasi
NO20041485L (no)	2004-04-13	Farmasoytisk formulering omfattende (R)-bicalutamid
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
DK1227817T3 (da)	2004-11-15	Ciclesonid-holdigt vandigt farmaceutisk præparat
NO20016430D0 (no)	2001-12-28	Farmasöytisk kompleks
NO20004816D0 (no)	2000-09-26	Ny farmasøytisk formulering
GB2392915B (en)	2004-04-28	Pharmaceutical formulation of fluticasone propionate
GB0312326D0 (en)	2003-07-02	Pharmaceutical formulation of fluticasone propionate